Pembrolizumab in Treating Younger Patients With Recurrent, Progressive, or Refractory High-Grade Gliomas, Diffuse Intrinsic Pontine Gliomas, Hypermutated Brain Tumors, Ependymoma or Medulloblastoma
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Cellectar Biosciences, Inc.
Children's Oncology Group
City of Hope Medical Center
Children's Oncology Group
Dana-Farber Cancer Institute
Emory University
National Cancer Institute (NCI)
Pediatric Brain Tumor Consortium
National Cancer Institute (NCI)
St. Jude Children's Research Hospital
Massachusetts General Hospital
Augusta University
University of Florida
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
GlaxoSmithKline